Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18273
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKatsanos, K. H.en
dc.contributor.authorChristodoulou, D.en
dc.contributor.authorSiozopoulou, V.en
dc.contributor.authorEufimia, B.en
dc.contributor.authorBali, C.en
dc.contributor.authorFatouros, M.en
dc.contributor.authorMitsi, V.en
dc.contributor.authorTsianos, E. V.en
dc.date.accessioned2015-11-24T18:51:30Z-
dc.date.available2015-11-24T18:51:30Z-
dc.identifier.issn1473-5687-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18273-
dc.rightsDefault Licence-
dc.subjectAdenocarcinoma/*etiology/pathology/surgeryen
dc.subjectBiopsyen
dc.subjectColitis, Ulcerative/*complications/pathologyen
dc.subjectColonoscopyen
dc.subjectEarly Detection of Cancer/methodsen
dc.subjectHumansen
dc.subjectIncidental Findingsen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectSigmoid Neoplasms/*etiology/pathology/surgeryen
dc.titleSilent ulcerative colitis adjacent to a regular sigmoid adenocarcinomaen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1097/MEG.0b013e328348a605-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/21799422-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2011-
heal.abstractThere have been studies trying to elucidate the large spectrum and the variety of inflammatory bowel disease (IBD)-related colorectal cancer manifestations and natural history. A 57-year-old male patient underwent a regular screening colonoscopy in our department, which revealed a flat ulcerated mass in the sigmoid whereas the remaining bowel was normal on endoscopic appearance. Biopsies from the mass were compatible with sigmoid adenocarcinoma and the patient underwent left hemicolectomy. Pathology examination of the resected specimen also diagnosed ulcerative colitis adjacent to cancer. The otherwise healthy patient denied any history that could be related to IBD symptoms. Patient was started on 1.6 g of mesalazine and was advised to adhere to an endoscopic surveillance program. This case points toward a need for a more thorough understanding of the natural history of colorectal cancer in IBD to set clinically meaningful guidelines.en
heal.journalNameEur J Gastroenterol Hepatolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons